NorthWest Biotherapeutics Inc (NWBO)

[Doktornolittle]

CLDX Data. Nobody talking about the IMUC Phase-2 follow-up data today? The stock tanked, but the data looked pretty good to me, within their recently narrowed subgroup targets.

For the proper genetic line, and for patients that respond to temador (mysenchimal mysenthropal non-mysnechymal) (whatever) it had pretty decent results.

To me, it bodes well for DCVax-L, for patients that respond to (now generic) Temador.

They concluded that they are going to include the patients that don't respond to Temador in their upcoming Phase 3 trial because that factor had no effect on the degree of immune response... which made absolutely no sense to say. The fact that they would say something that made no sense did concern me.

Recall that NWBO defined a very large number of subgroups at some point. Given that fact, I don't see how a failure could be likely. A partial failure seems somewhat likely. A complete failure... seems very very unlikely.

Mushy-Logic

The mush-mellon vs the steel-traps. I think I've got em!!!!!!! No way out!

I therefore predict no bad news Monday morning!